These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9093953)

  • 41. On 100 hue test.
    Maione M; Carta F; Barberini E
    Mod Probl Ophthalmol; 1974; 13(0):67-72. PubMed ID: 4548156
    [No Abstract]   [Full Text] [Related]  

  • 42. Brightness sensitivity and color perception as predictors of relative afferent pupillary defect.
    Danesh-Meyer HV; Papchenko TL; Savino PJ; Gamble GD
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3616-21. PubMed ID: 17652731
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SITA standard in optic neuropathies and hemianopias: a comparison with full threshold testing.
    Wall M; Punke SG; Stickney TL; Brito CF; Withrow KR; Kardon RH
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):528-37. PubMed ID: 11157893
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of Uhthoff's symptom in disseminated sclerosis by the Farnsworth-Munsell 100-hue test and the octopus perimetry.
    Zrenner E
    Dev Ophthalmol; 1984; 9():182-7. PubMed ID: 6335437
    [No Abstract]   [Full Text] [Related]  

  • 45. Imaging of the optic disc and retinal nerve fiber layer in acute optic neuritis.
    Pro MJ; Pons ME; Liebmann JM; Ritch R; Zafar S; Lefton D; Kupersmith MJ
    J Neurol Sci; 2006 Dec; 250(1-2):114-9. PubMed ID: 17027854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial.
    Katz B
    Trans Am Ophthalmol Soc; 1995; 93():685-708. PubMed ID: 8719696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Dyschromatopsia in optic neuropathies. Classification].
    Lanthony P
    Bull Soc Ophtalmol Fr; 1985 Mar; 85(3):385-9. PubMed ID: 4092338
    [No Abstract]   [Full Text] [Related]  

  • 48. Eigenvector interpretation of the Farnsworth-Munsell 100-hue test.
    Mantere K; Parkkinen J; Mäntyjärvi M; Jaaskelainen T
    J Opt Soc Am A Opt Image Sci Vis; 1995 Oct; 12(10):2237-43. PubMed ID: 7500204
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The color vision in patients with optic neuritis and chronic open-angle glaucoma].
    Huang S; Wu L; Wu DZ
    Yan Ke Xue Bao; 1991 Jun; 7(2):92-4. PubMed ID: 1844067
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contrast sensitivity and other vision tests in the optic neuritis treatment trial.
    Trobe JD; Beck RW; Moke PS; Cleary PA
    Am J Ophthalmol; 1996 May; 121(5):547-53. PubMed ID: 8610798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequency of colour vision deficiencies in melanoma patients: results of a prospective comparative screening study with the Farnsworth panel D 15 test including 300 melanoma patients and 100 healthy controls.
    Pföhler C; Tschöp S; König J; Rass K; Tilgen W
    Melanoma Res; 2006 Oct; 16(5):413-21. PubMed ID: 17013090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can color vision defective subjects who pass the farnsworth lantern test recognize surface color codes?
    Cole BL; Lian KY; Lakkis C
    Aviat Space Environ Med; 2007 Jan; 78(1):21-5. PubMed ID: 17225477
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new color vision test to differentiate congenital and acquired color vision defects.
    Shin YJ; Park KH; Hwang JM; Wee WR; Lee JH
    Ophthalmology; 2007 Jul; 114(7):1341-7. PubMed ID: 17296231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Computer method for evaluating disorders in sense of color].
    Shamshinova AM; Petrov AS; Dvorianchikova AP; Aref'eva IuA; Eskina EN; Kiseleva TN; Zol'nikova IV
    Vestn Oftalmol; 2000; 116(5):49-51. PubMed ID: 11221383
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Disorder in color perception--a primary sign of optic-nerve inflammation].
    Malec J
    Cesk Oftalmol; 1978 Sep; 34(5):327-30. PubMed ID: 308866
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical color vision testing and correlation with visual function.
    Zhao J; Davé SB; Wang J; Subramanian PS
    Am J Ophthalmol; 2015 Sep; 160(3):547-552.e1. PubMed ID: 26116263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Importance of preventing retrobulbar optic neuropathy from ethambutol by the determination of zinc in the blood and by the Farnsworth test of color sense].
    Minutillo U; Alvaro Miniero M; Severino R; De Rosa G; Pezza A; Erpici M; Papparella AM
    Arch Monaldi; 1980; 35(4):217-28. PubMed ID: 7342904
    [No Abstract]   [Full Text] [Related]  

  • 58. [Results of clinical tests of color vision in multiple sclerosis].
    Pinckers A; Verriest G
    Bull Soc Belge Ophtalmol; 1982; 199-200():131-44. PubMed ID: 6985030
    [No Abstract]   [Full Text] [Related]  

  • 59. A new computer-based Farnsworth Munsell 100-hue test for evaluation of color vision.
    Ghose S; Parmar T; Dada T; Vanathi M; Sharma S
    Int Ophthalmol; 2014 Aug; 34(4):747-51. PubMed ID: 24097078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of high-resolution MRI of the optic nerve in Graves' ophthalmopathy.
    Dodds NI; Atcha AW; Birchall D; Jackson A
    Br J Radiol; 2009 Jul; 82(979):541-4. PubMed ID: 19124566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.